International standards for tuberculosis care (Q36635875)

15 August 2017

1 reference

title

International standards for tuberculosis care. (English)

1 reference

15 August 2017

0 references

Dermot Maher

3

0 references

Mario Raviglione

object named as

Mario C Raviglione

series ordinal

5

0 references

Madhukar Pai

object named as

Madhukar Pai

series ordinal

2

0 references

Philip C Hopewell

series ordinal

1

object named as

Philip C Hopewell

1 reference

15 August 2017

4

Mukund Uplekar

1 reference

15 August 2017

1 November 2006

1 reference

Lancet Infectious Diseases

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

11

1 reference

15 August 2017

710-725

1 reference

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Tuberculosis, vulnerability, and access to quality care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Private practitioners and public health: weak links in tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Treatment of tuberculosis by private general practitioners in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

WHO's new Stop TB Strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Diagnosing tuberculosis in a resource-poor setting: the value of a trial of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Advances in the diagnosis and treatment of tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Diagnosis and treatment of tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

The challenge of diagnosing tuberculosis in children: a perspective from a high incidence area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Tuberculosis in children: considerations for children from developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Childhood pulmonary tuberculosis: old wisdom and new challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Hong Kong Chest Service/British Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Directly observed therapy for tuberculosis given twice weekly in the workplace in urban South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Directly observed therapy for treating tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Directly observed therapy and treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Can tuberculosis be controlled?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Tuberculosis and HIV/AIDS: epidemiological and clinical aspects (world perspective).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Tuberculosis control in the era of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Transmission of multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Management of multidrug-resistant tuberculosis and patients in retreatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Programmes and principles in treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Drug-susceptibility testing in tuberculosis: methods and reliability of results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Contact investigations and the continued commitment to control tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

Evaluation of investigations conducted to detect and prevent transmission of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970628-4

7 January 2021

10.1016/S1473-3099(06)70628-4

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17067920